CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Total
Beginning Balance at Dec. 31, 2018	$ 21,170	$ 89,101	$ (3,478)	$ 106,793
Balances (in shares) at Dec. 31, 2018	5,955,242
Increase (Decrease) in Stockholders' Equity
Common stock issued - stock grants	$ 295			295
Common stock issued - stock grants (in shares)	26,084
Stock compensation expense	$ 56			56
Other comprehensive Income (loss)			2,769	2,769
Net income		2,811		2,811
Dividends declared		(1,015)		(1,015)
Ending Balance at Mar. 31, 2019	$ 21,521	90,897	(709)	111,709
Balances (in shares) at Mar. 31, 2019	5,981,326
Beginning Balance at Dec. 31, 2019	$ 21,447	96,903	913	119,263
Balances (in shares) at Dec. 31, 2019	5,913,922
Increase (Decrease) in Stockholders' Equity
Common stock issued - stock grants	$ 263			263
Common stock issued - stock grants (in shares)	33,076
Stock compensation expense	$ 61			61
Other comprehensive Income (loss)			(2,481)	(2,481)
Net income		1,751		1,751
Dividends declared		(1,070)		(1,070)
Ending Balance at Mar. 31, 2020	$ 21,771	$ 97,584	$ (1,568)	$ 117,787
Balances (in shares) at Mar. 31, 2020	5,946,998